{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T22:38:50Z","timestamp":1775687930216,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1124\/mol.109.056283","type":"journal-article","created":{"date-parts":[[2009,6,10]],"date-time":"2009-06-10T04:04:13Z","timestamp":1244606653000},"page":"552-559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Human 5-HT7 Receptor-Induced Inactivation of Forskolin-Stimulated Adenylate Cyclase by Risperidone, 9-OH-Risperidone and Other \u201cInactivating Antagonists\u201d"],"prefix":"10.1016","volume":"76","author":[{"given":"Nicole","family":"Toohey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael T.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Knight","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milt","family":"Teitler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/mol.109.056283_bib1","doi-asserted-by":"crossref","unstructured":"Alousi AA, Jasper JR, Insel PA, and Motulsky HJ (1991) Stoichiometry of receptor-Gs-adenylate cyclase interactions. FASEB J 5: 2300-2303.","DOI":"10.1096\/fasebj.5.9.1650314"},{"key":"10.1124\/mol.109.056283_bib2","doi-asserted-by":"crossref","unstructured":"Bard JA, Zgombick J, Adham N, Vaysse P, Branchek TA, and Weinshank RL (1993) Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase. J Biol Chem 268: 23422-23426.","DOI":"10.1016\/S0021-9258(19)49479-9"},{"key":"10.1124\/mol.109.056283_bib3","unstructured":"Bender JL, Wolf LG, and Neer EJ (1984) Interaction of forskolin with resolved adenylate cyclase components. Adv Cyclic Nucleotide Protein Phosphorylation Res 17: 101-109."},{"key":"10.1124\/mol.109.056283_bib4","doi-asserted-by":"crossref","unstructured":"Bhana N and Spencer CM (2000) Risperidone: a review of its use in the management of the behavioural and psychological symptoms of dementia. Drugs Aging 16: 451-471.","DOI":"10.2165\/00002512-200016060-00005"},{"key":"10.1124\/mol.109.056283_bib5","doi-asserted-by":"crossref","unstructured":"Darfler FJ, Mahan LC, Koachman AM, and Insel PA (1982) Stimulation of forskolin of intact S49 lymphoma cells involves the nucleotide regulatory protein of adenylate cyclase. J Biol Chem 257: 11901-11907.","DOI":"10.1016\/S0021-9258(18)33651-2"},{"key":"10.1124\/mol.109.056283_bib6","doi-asserted-by":"crossref","unstructured":"Dessauer CW, Scully TT, and Gilman AG (1997) Interactions of forskolin and ATP with the cytosolic domains of mammalian adenylyl cyclase. J Biol Chem 272: 22272-22277.","DOI":"10.1074\/jbc.272.35.22272"},{"key":"10.1124\/mol.109.056283_bib7","doi-asserted-by":"crossref","unstructured":"Gerhardt CC and van Heerikhuizen H (1997) Functional characteristics of heterologously expressed 5-HT receptors. Eur J Pharmacol 334: 1-23.","DOI":"10.1016\/S0014-2999(97)01115-1"},{"key":"10.1124\/mol.109.056283_bib8","doi-asserted-by":"crossref","unstructured":"Green B (2000) Focus on risperidone. Curr Med Res Opin 16: 57-65.","DOI":"10.1185\/030079900542830"},{"key":"10.1124\/mol.109.056283_bib9","doi-asserted-by":"crossref","unstructured":"Hedlund PB and Sutcliffe JG (2004) Functional, molecular and pharmacological advances in 5-HT7 receptor research. Trends Pharmacol Sci 25: 481-486.","DOI":"10.1016\/j.tips.2004.07.002"},{"key":"10.1124\/mol.109.056283_bib10","doi-asserted-by":"crossref","unstructured":"Hoyer D, Hannon JP, and Martin GR (2002) Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71: 533-554.","DOI":"10.1016\/S0091-3057(01)00746-8"},{"key":"10.1124\/mol.109.056283_bib11","doi-asserted-by":"crossref","unstructured":"Hoyer D and Martin G (1997) 5-HT receptor classification and nomenclature: towards a harmonization with the human genome. Neuropharmacology 36: 419-428.","DOI":"10.1016\/S0028-3908(97)00036-1"},{"key":"10.1124\/mol.109.056283_bib12","doi-asserted-by":"crossref","unstructured":"Insel PA and Ostrom RS (2003) Forskolin as a tool for examining adenylyl cyclase expression, regulation, and G protein signaling. Cell Mol Neurobiol 23: 305-314.","DOI":"10.1023\/A:1023684503883"},{"key":"10.1124\/mol.109.056283_bib13","doi-asserted-by":"crossref","unstructured":"Kaslow HR, Lim LK, Moss J, and Lesikar DD (1987) Structure-activity analysis of the activation of pertussis toxin. Biochemistry 26: 123-127.","DOI":"10.1021\/bi00375a018"},{"key":"10.1124\/mol.109.056283_bib14","doi-asserted-by":"crossref","unstructured":"Knight JA, Smith C, Toohey N, Klein MT, and Teitler M (2009) Pharmacological analysis of the novel, rapid, and potent inactivation of the human 5-hydroxytryptamine7 receptor by risperidone, 9-OH-risperidone, and other inactivating antagonists. Mol Pharmacol 75: 374-380.","DOI":"10.1124\/mol.108.052084"},{"key":"10.1124\/mol.109.056283_bib15","doi-asserted-by":"crossref","unstructured":"Krobert KA, Andressen KW, and Levy FO (2006) Heterologous desensitization is evoked by both agonist and antagonist stimulation of the human 5-HT(7) serotonin receptor. Eur J Pharmacol 532: 1-10.","DOI":"10.1016\/j.ejphar.2005.11.039"},{"key":"10.1124\/mol.109.056283_bib16","doi-asserted-by":"crossref","unstructured":"Kroeze WK, Kristiansen K, and Roth BL (2002) Molecular biology of serotonin receptors\u2014structure and function at the molecular level. Curr Top Med Chem 2: 507-528.","DOI":"10.2174\/1568026023393796"},{"key":"10.1124\/mol.109.056283_bib17","doi-asserted-by":"crossref","unstructured":"Love RC and Nelson MW (2000) Pharmacology and clinical experience with risperidone. Expert Opin Pharmacother 1: 1441-1453.","DOI":"10.1517\/14656566.1.7.1441"},{"key":"10.1124\/mol.109.056283_bib18","doi-asserted-by":"crossref","unstructured":"Lovenberg TW, Baron BM, de Lecea L, Miller JD, Prosser RA, Rea MA, Foye PE, Racke M, Slone AL, and Siegel BW. (1993) A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms. Neuron 11: 449-458.","DOI":"10.1016\/0896-6273(93)90149-L"},{"key":"10.1124\/mol.109.056283_bib19","doi-asserted-by":"crossref","unstructured":"Meltzer HY, Matsubara S, and Lee JC (1989) Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 PKi values. J Pharmacol Exp Ther 251: 238-246.","DOI":"10.1016\/S0022-3565(25)20710-8"},{"key":"10.1124\/mol.109.056283_bib20","doi-asserted-by":"crossref","unstructured":"Mons N and Cooper DM (1995) Adenylate cyclases: critical foci in neuronal signaling. Trends Neurosci 18: 536-542.","DOI":"10.1016\/0166-2236(95)98375-9"},{"key":"10.1124\/mol.109.056283_bib21","unstructured":"Neer EJ (1978) Multiple forms of adenylate cyclase. Adv Cyclic Nucleotide Res 9: 69-83."},{"key":"10.1124\/mol.109.056283_bib22","unstructured":"Neer EJ (1986) Guanine nucleotide-binding proteins involved in transmembrane signaling. Symp Fundam Cancer Res 39: 123-136."},{"key":"10.1124\/mol.109.056283_bib23","doi-asserted-by":"crossref","unstructured":"Raymond JR, Mukhin YV, Gelasco A, Turner J, Collinsworth G, Gettys TW, Grewal JS, and Garnovskaya MN (2001) Multiplicity of mechanisms of serotonin receptor signal transduction. Pharmacol Ther 92: 179-212.","DOI":"10.1016\/S0163-7258(01)00169-3"},{"key":"10.1124\/mol.109.056283_bib24","doi-asserted-by":"crossref","unstructured":"Roth BL, Craigo SC, Choudhary MS, Uluer A, Monsma FJ, Jr., Shen Y, Meltzer HY, and Sibley DR (1994) Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J Pharmacol Exp Ther 268: 1403-1410.","DOI":"10.1016\/S0022-3565(25)38596-4"},{"key":"10.1124\/mol.109.056283_bib25","doi-asserted-by":"crossref","unstructured":"Schneider LS, Dagerman K, and Insel PS (2006) Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry 14: 191-210.","DOI":"10.1097\/01.JGP.0000200589.01396.6d"},{"key":"10.1124\/mol.109.056283_bib26","doi-asserted-by":"crossref","unstructured":"Shen Y, Monsma FJ, Jr., Metcalf MA, Jose PA, Hamblin MW, and Sibley DR (1993) Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. J Biol Chem 268: 18200-18204.","DOI":"10.1016\/S0021-9258(17)46830-X"},{"key":"10.1124\/mol.109.056283_bib27","doi-asserted-by":"crossref","unstructured":"Smith C, Rahman T, Toohey N, Mazurkiewicz J, Herrick-Davis K, and Teitler M (2006) Risperidone irreversibly binds to and inactivates the h5-HT7 serotonin receptor. Mol Pharmacol 70: 1264-1270.","DOI":"10.1124\/mol.106.024612"},{"key":"10.1124\/mol.109.056283_bib28","doi-asserted-by":"crossref","unstructured":"Stengel D, Guenet L, Desmier M, Insel P, and Hanoune J (1982) Forskolin requires more than the catalytic unit to activate adenylate cyclase. Mol Cell Endocrinol 28: 681-690.","DOI":"10.1016\/0303-7207(82)90155-1"},{"key":"10.1124\/mol.109.056283_bib29","doi-asserted-by":"crossref","unstructured":"Tang WJ and Gilman AG (1995) Construction of a soluble adenylyl cyclase activated by Gs alpha and forskolin. Science 268: 1769-1772.","DOI":"10.1126\/science.7792604"},{"key":"10.1124\/mol.109.056283_bib30","doi-asserted-by":"crossref","unstructured":"Taussig R, I\u00f1iguez-Lluhi JA, and Gilman AG (1993) Inhibition of adenylyl cyclase by Gi alpha. Science 261: 218-221.","DOI":"10.1126\/science.8327893"},{"key":"10.1124\/mol.109.056283_bib31","unstructured":"Teitler M and Herrick-Davis K (1994) Multiple serotonin receptor subtypes: molecular cloning and functional expression. Crit Rev Neurobiol 8: 175-188."},{"key":"10.1124\/mol.109.056283_bib32","doi-asserted-by":"crossref","unstructured":"Terr\u00f3n JA (1997) Role of 5-ht7 receptors in the long-lasting hypotensive response induced by 5-hydroxytryptamine in the rat. Br J Pharmacol 121: 563-571.","DOI":"10.1038\/sj.bjp.0701134"},{"key":"10.1124\/mol.109.056283_bib33","doi-asserted-by":"crossref","unstructured":"Tesmer JJ, Sunahara RK, Fancy DA, Gilman AG, and Sprang SR (2002) Crystallization of complex between soluble domains of adenylyl cyclase and activated Gs alpha. Methods Enzymol 345: 198-206.","DOI":"10.1016\/S0076-6879(02)45017-3"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24020200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24020200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.109.056283","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:39:04Z","timestamp":1739957944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24020200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0026895X24020200"],"URL":"https:\/\/doi.org\/10.1124\/mol.109.056283","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human 5-HT7 Receptor-Induced Inactivation of Forskolin-Stimulated Adenylate Cyclase by Risperidone, 9-OH-Risperidone and Other \u201cInactivating Antagonists\u201d","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.109.056283","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2009 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}